Skip to main content
Premium Trial:

Request an Annual Quote

Nanosphere Signs Deal With Takara Bio For Distribution, Research

NEW YORK, July 23-Nanosphere said yesterday that it had formed a distribution and development agreement with the Japanese firm Takara Bio.

 

Under the agreement, Takara will be the exclusive Nanosphere distributor in Asia, and have non-exclusive distribution rights in Europe.

 

The two companies will also work to develop portable protein and nucleic acid identification systems that combine Nanosphere's DNA probe technology with Takara's gene amplification techniques.

 

Further, Takara will make an equity investment in Nanosphere.

 

Specific financial details of the agreement were not disclosed.

 

Nanosphere is a privately held assay firm based in Northbrook, Ill.

 

Takara Bio, based in Otsu, Japan, is a biotechnology subsidiary of Takara Holdings.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.